In summary, our data showed that hsa_circ_0037128 could promote HG-induced podocytes injury_ia_egulating miR-31-5p/KLF9 axis, showing that hsa_circ_0037128 might be a target for DN treatment.
Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9.